Clinical Trials Logo

Clinical Trial Summary

The purpose of this survey is to collect visual acuity data from patients with LHON in order to establish the clinical course (natural history) and visual acuity outcomes in patients with a genetically confirmed diagnosis of LHON. In addition, this survey will generate data that will serve as comparator for the open-label study SNT-IV-006.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02796274
Study type Observational
Source Santhera Pharmaceuticals
Contact
Status Completed
Phase
Start date May 2016
Completion date July 2018

See also
  Status Clinical Trial Phase
Completed NCT02771379 - Post Authorisation Safety Study With Raxone in LHON Patients
Completed NCT02774005 - Study to Assess the Efficacy and Safety of Raxone in LHON Patients Phase 4
Recruiting NCT04912843 - Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy Phase 2/Phase 3
Terminated NCT01389817 - Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON) Phase 1/Phase 2
Completed NCT05555784 - Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection